CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Cancer Intervention: Drug: CEND-1 Sponsors: Qilu Pharmaceutical Co., Ltd.; Cend Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials